Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 661 across all filing types
Latest filing 2026-03-24 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司部分募投项目结项并将节余募集资金永久补充流动资金及部分募投项目延期的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the completion and fund usage of certain fundraising investment projects by Shenzhen Huitai Medical Devices Co., Ltd. It discusses the use of proceeds from the company's initial public offering (IPO), project completion status, surplus fund allocation, and project delays. The document references regulatory approvals, fundraising amounts, project investment adjustments, and compliance with relevant securities regulations. It is not a full annual or interim financial report, nor is it a simple announcement or certification. The content focuses on fundraising project status, fund usage, and related compliance verification, which aligns with a Capital/Financing Update (CAP) filing type. The document length is about 4741 characters, which is substantive and contains detailed financial and project information, not just an announcement or summary. Therefore, the best classification is Capital/Financing Update (CAP).
2026-03-24 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled "深圳惠泰医疗器械股份有限公司2025 年年度报告" which translates to "APT Medical Inc. 2025 Annual Report." It contains detailed sections typical of an annual report, including company overview, financial data for the year 2025, management discussion and analysis, corporate governance, risk factors, and audited financial statements. The document is extensive (15,000 characters) and includes comprehensive financial and operational information for the full fiscal year 2025. It also references the audit report by an accounting firm but is not just the audit report itself. The presence of detailed financial statements, management analysis, and full-year data confirms this is the official annual report for the company for the year 2025. Therefore, the correct classification is Annual Report (10-K). FY 2025
2026-03-24 Chinese
关于会计师事务所2025年度履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm for the year 2025, specifically regarding their audit duties for Shenzhen Huitai Medical Devices Co., Ltd. It details the qualifications, independence, quality control, and overall assessment of the audit firm (Lixin CPA Firm) for the 2025 audit year. The content focuses on the audit firm's performance and quality management rather than presenting the company's financial statements or audit results themselves. The document is about the audit firm's evaluation and their audit engagement, not the audit report or the annual report itself. It is a standalone audit-related report concerning the audit firm's performance and compliance with professional standards. Therefore, it fits best under the category of Audit Report / Information (AR). The document length is 3256 characters, which is relatively short but contains substantive audit evaluation content, not just an announcement or certification. Hence, it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). FY 2025
2026-03-24 Chinese
关于公司部分募投项目结项并将节余募集资金永久补充流动资金及部分募投项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding the completion of certain fundraising investment projects, the permanent supplementation of surplus raised funds into working capital, and the postponement of some fundraising projects. It details the use of funds raised from the company's initial public offering (IPO) in 2021, including specific project names, amounts, and adjustments. The document includes information about the board of directors' approval and the sponsor's opinion, confirming compliance with regulatory requirements. There are no financial statements or detailed financial performance data presented, nor is this a transcript, report, or presentation. The document is a regulatory announcement about the use and management of raised capital and project progress, fitting the category of Capital/Financing Update (CAP).
2026-03-24 Chinese
2025年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as "2025 年年度报告摘要" which translates to "2025 Annual Report Summary". It contains detailed financial data for the year 2025, including total assets, net profit, revenue, quarterly financial data, shareholder information, business overview, industry analysis, and risk disclosures. The length of the document is over 14,000 characters, indicating it is a substantive report rather than a brief announcement. The content includes management discussion and analysis, financial metrics, and business operations, which are typical components of an Annual Report. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2025
2026-03-24 Chinese
关于股份回购实施结果暨股份变动的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement about the implementation results of a share repurchase program by Shenzhen Huitai Medical Device Co., Ltd. It includes specifics such as the number of shares repurchased, the price range, the total amount spent, the purpose of the repurchase (employee stock ownership plan or equity incentives), and the impact on shareholding structure. It also references previous announcements related to the repurchase plan and confirms completion of the repurchase. The document is not a financial report, earnings release, or regulatory filing but a specific announcement about the company's transaction in its own shares (share buyback). Therefore, it fits the category of Transaction in Own Shares (POS). The document length is 2182 characters, which is sufficient for a detailed announcement rather than a brief notice or report publication announcement. Hence, the classification is POS with high confidence.
2026-03-10 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.